Global Cardio-selective Beta Blockers Market to Surpass USD 10.1 Billion by 2031 Amid Rising Cardiovascular Disease Burden
The global cardio-selective beta blockers market is witnessing steady growth due to the increasing prevalence of cardiovascular diseases (CVDs), growing geriatric population, and rising demand for effective and safer treatment options. Valued at US$ 6.2 billion in 2022, the market is projected to expand at a CAGR of 5.7% from 2023 to 2031 and exceed US$ 10.1 billion by the end of the forecast...
0 Comments 0 Shares 99 Views 0 Reviews
Sponsored

🤑 Turn Clicks into Cash

Passive income unlocked! Share your link, bring users, and get paid every month. Adsterra makes it simple 💰